{
    "code": "52026698",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026698",
    "time": "2019-11-08 03:05:12",
    "許可證字號": "衛部藥輸字第026698號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/12\/08",
    "發證日期": "104\/12\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202669804",
    "中文品名": "歐癬平凍晶注射劑",
    "英文品名": "Voriconazole Sandoz Lyophilized Powder for Injection",
    "適應症": "一、治療侵犯性麴菌病（INVASIVE ASPERGILLOSIS）﹔二、治療嚴重之侵犯性念珠菌感染（SERIOUS INVASIVE CANDIDA INFECTIONS）﹔三、治療足分枝菌（SCEDOSPORIUM SPP.）和鐮刀菌（FUSARIUM SPP.）之嚴重黴菌感染﹔四、預防高危險患者發生侵入性黴菌感染，包括接受造血幹細胞移植（HSCT）的患者。",
    "劑型": "243凍晶注射劑",
    "包裝": "200毫克小瓶 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "VORICONAZOLE",
    "主製造廠": {
        "申請商名稱": "0924601100  台灣諾華股份有限公司",
        "申請商地址": "台北市中山區民生東路三段2號8樓",
        "主製造廠": "",
        "製造廠名稱": "FSI0004000  LEK PHARMACEUTICALS D.D., SLOVENIA"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812204300",
            "成分名稱": "VORICONAZOLE",
            "含量描述": "",
            "含量": "211.3000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Voriconazole LYVI_TWI-200116-105-04-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026698&Seq=001&Type=9"
        },
        {
            "title": "Voriconazole LYVI_LB-105-04-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026698&Seq=002&Type=8"
        }
    ]
}